Skip to main content
. 2014 Feb 26;32(10):1139–1146. doi: 10.1016/j.vaccine.2014.01.008

Fig. 4.

Fig. 4

L1L2 pseudovirus neutralization titers prior to and post antibody enrichment on non-vaccine L1 VLP.

Serum samples (A–F) were enriched on VLP representing non-vaccine A9 types. The neutralization titer against pseudoviruses (PsV) representing HPV16, HPV31 and another relevant type were determined for the serum samples prior to and post enrichment.